{
    "2019-09-24": [
        [
            {
                "time": "",
                "original_text": "靓点与质疑：港股转战科创板的玻尿酸龙头华熙生物",
                "features": {
                    "keywords": [
                        "港股",
                        "科创板",
                        "玻尿酸",
                        "华熙生物"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}